Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance

Combined glucose-lowering therapy, comprising of basal insulin with glucagon-like peptide-1 (GLP-1) analogues, has become central to the treatment of type 2 diabetes both at the start of insulin therapy, and as an alternative to basal-bolus insulin. The combination of insulin detemir (insulin analog...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lyudmila Alexandrovna Ruyatkina, Maxim Sorokin
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2017
Materias:
Acceso en línea:https://doaj.org/article/3e6b1c403d2245b08a42415262fb3420
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!